Competition

Competition Law360 provides breaking news and analysis on antitrust law. Coverage includes high-stakes antitrust litigation and government enforcement actions, as well as legislative and regulatory developments.



Sign up for a 7-day FREE trial today!



Latest News in Competition

  • August 05, 2026

    Grocery Chains Accuse Refined Sugar Cos. Of Price-Fixing

    Several grocery chains, including Albertsons and Kroger, have accused a group of refined sugar companies including Domino Sugar of conspiring to artificially raise the cost of refined sugar through a "give to get" arrangement.

  • August 05, 2026

    Drug Cos. Can't Trim Humana's Price-Fix Claims In Bellwether

    A Pennsylvania federal judge on Tuesday denied a bid by a number of generic drug manufacturers to dismiss two antitrust claims brought by health insurer Humana Inc. from an upcoming bellwether trial in long-running antitrust multidistrict litigation, finding they were brought within the statute of limitations.

  • August 05, 2026

    DOJ Pulls ISS Letter, Signals Possible Antitrust Enforcement

    The Justice Department's Antitrust Division signaled Wednesday that it may take enforcement action against Institutional Shareholder Services, withdrawing a 1987 letter stating the division would not do so and flagging "significant competition concerns" about the concentration of proxy advisory market power.

  • August 05, 2026

    Bang Energy's Ex-CEO Gets Loan Approval To Fund Defense

    A Florida bankruptcy judge approved a loan Wednesday for a company managed by Bang Energy founder Jack Owoc to allow him to fund his defense in litigation filed by the trustee overseeing the energy drinks manufacturer's bankrupt estate.

  • August 05, 2026

    Takeda Says Rebates, Subsidies Cut $885M IBS Drug Verdict

    Takeda Pharmaceuticals battled with a class of health plans over whether a Massachusetts federal jury's $885 million antitrust verdict against the drugmaker for conspiring to delay generic competition to anticonstipation drug Amitiza should be reduced by rebates the drugmaker paid and Medicare subsidies that reduced the health plans' costs.

See more Competition news

Competition

Areas of Coverage

  • AGENCIES
  • U.S. Department of Justice, Antitrust Division
  • Federal Trade Commission, Bureau of Competition
  • European Commission, Competition Directorate
  • UK Competition and Markets Authority
  • Germany’s Federal Cartel Office
  • China’s Ministry Of Commerce
  • Japan Fair Trade Commission
  • Korea Fair Trade Commission
  • Canada’s Competition Bureau
  • Brazil’s Council for Economic Defense
  • POLICY & REGULATION
  • Clayton Act
  • Federal Trade Commission Act
  • Foreign Corrupt Practices Act
  • Racketeer Influenced and Corrupt Organizations Act
  • Robinson-Patman Act
  • Sherman Act
  • International antitrust legislation and regulation
  • ENFORCEMENT
  • Criminal charges over antitrust issues
  • Global cartel investigations and actions
  • Merger reviews and second requests
  • Merger challenges and divestiture orders
  • Anti-monopoly actions
  • Pharmaceutical pay-for-delay challenges
  • Bid-rigging probes
  • Kickback, bribery, and corruption cases
  • Challenges to state aid and other subsidies
  • LITIGATION
  • Antitrust class actions
  • Price-fixing cases
  • Illegal monopoly suits
  • PROFILES
  • Personnel moves
  • Profiles of competition practices

Readership

  • Antitrust and competition lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals